Journal of Clinical and Experimental Ophthalmology
Open Access

Novel targeted treatments for metastatic uveal melanoma

4^th International Conference on Clinical & Experimental Ophthalmology

July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Shahar Frenkel

Accepted Abstracts: J Clin Exp Ophthalmol

Abstract :

Noor Bakht Nizamani is an FRCSEd & MS (Ophthalmology) resident at Liaquat University of Medical and Health Sciences (LUMHS), Pakistan. She graduated from LUMHS in 2009 with double distinction in Ophthalmology and Obstetrics & Gynecology. She is a vivacious presenter with over 20 presentations at renowned conferences including 2 international conferences. She has over 7 peer reviewed publications and she serves as a reviewer for BMJ Case Reports. She is the author of Basic Ophthalmology, a concise book for Ophthalmology residents

Biography :

Shahar Frenkel has completed his dual MD/Ph.D.degree at the age of 26 years from the Hebrew University of Jerusalem and Postdoctoral studies in University of Illinois at Chicago, and Hadassah-Hebrew University Medical Center. He is an Ocular Oncologist and Ophthalmic Pathologist, and heads a research group aimed at finding novel therapies for uveal melanoma. He has served on the managing board of the International Society of Ocular Oncology. He has published more than 35 papers in reputed journals and has been has been reviewing manuscripts for a number of leading ophthalmic journals.